ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Jazz Pharmaceuticals Announces Acquisition of Cavion
August 14, 2019Jazz Pharmaceuticals announced the acquisition of Cavion through a merger with a Jazz subsidiary. Under the terms of the agreement, the former Cavion shareholders receive an upfront payment of $52.5 million and have the potential to receive additional pay -
First Patient Enrolled in Cavion Multi-Center Phase 2 Clinical Trial in Epilepsy
March 21, 2018Cavion, Inc. announced today that the first patient has been enrolled in its innovative T-WAVE Phase 2a proof-of-concept clinical trial (NCT03406702).
Pharma Sources Insight January 2025
